TY - JOUR
T1 - Gut and liver T cells of common clonal origin are detected in primary sclerosing cholangitis-inflammatory bowel disease
AU - Henriksen, Eva Kristine Klemsdal
AU - Jørgensen, Kristin Kaasen
AU - Kaveh, Fatemah
AU - Holm, Kristian
AU - Hamm, David
AU - Olweus, Johanna
AU - Melum, Espen
AU - Chung, Brian
AU - Eide, Tor J
AU - Lundin, Knut EA
AU - Boberg, Kirsten Muri
AU - Karlsen, Tom Hemming
AU - Hirschfield, Gideon
AU - Liaskou, Evaggelia
N1 - JHEPAT-D-16-00495R2 - Manuscript number
PY - 2016/9/17
Y1 - 2016/9/17
N2 - Background & Aims: Recruitment of gut-derived memory T cells to the liveris believed to drive hepatic inflammation in primary sclerosing cholangitis(PSC). However, whether gut-infiltrating and liver-infiltrating T cells share Tcellreceptors (TCRs) and antigenic specificities is unknown. We used pairedgut and liver samples from PSC patients with concurrent inflammatory boweldisease (PSC-IBD), and normal tissue samples from colon cancer controls, toassess potential T-cell clonotype overlap between the two compartments.Methods: High-throughput sequencing of TCRβ repertoires was applied onmatched colon, liver and blood samples from patients with PSC-IBD (n=10),and on paired tumor-adjacent normal gut and liver tissue samples from coloncancer patients (n=10).Results: An average of 9.7% (range: 4.7–19.9%) memory T-cell clonotypesoverlapped in paired PSC-IBD affected gut and liver samples, after excludingclonotypes present at similar frequencies in blood. Shared clonotypesconstituted on average 16.0% (range: 8.7–32.6%) and 15.0% (range: 5.9–26.3%) of the liver and gut memory T cells, respectively. A significantly higheroverlap was observed between paired PSC-IBD affected samples (8.7%,p=0.0007) compared to paired normal gut and liver samples (3.6%), afterdownsampling to equal number of reads.Conclusion: Memory T cells of common clonal origin were detected in pairedgut and liver samples of patients with PSC-IBD. Our data indicate that this isrelated to PSC-IBD pathogenesis, suggesting that memory T cells driven byshared antigens are present in the gut and liver of PSC-IBD patients. Ourfindings support efforts to therapeutically target memory T-cell recruitment inPSC-IBD.
AB - Background & Aims: Recruitment of gut-derived memory T cells to the liveris believed to drive hepatic inflammation in primary sclerosing cholangitis(PSC). However, whether gut-infiltrating and liver-infiltrating T cells share Tcellreceptors (TCRs) and antigenic specificities is unknown. We used pairedgut and liver samples from PSC patients with concurrent inflammatory boweldisease (PSC-IBD), and normal tissue samples from colon cancer controls, toassess potential T-cell clonotype overlap between the two compartments.Methods: High-throughput sequencing of TCRβ repertoires was applied onmatched colon, liver and blood samples from patients with PSC-IBD (n=10),and on paired tumor-adjacent normal gut and liver tissue samples from coloncancer patients (n=10).Results: An average of 9.7% (range: 4.7–19.9%) memory T-cell clonotypesoverlapped in paired PSC-IBD affected gut and liver samples, after excludingclonotypes present at similar frequencies in blood. Shared clonotypesconstituted on average 16.0% (range: 8.7–32.6%) and 15.0% (range: 5.9–26.3%) of the liver and gut memory T cells, respectively. A significantly higheroverlap was observed between paired PSC-IBD affected samples (8.7%,p=0.0007) compared to paired normal gut and liver samples (3.6%), afterdownsampling to equal number of reads.Conclusion: Memory T cells of common clonal origin were detected in pairedgut and liver samples of patients with PSC-IBD. Our data indicate that this isrelated to PSC-IBD pathogenesis, suggesting that memory T cells driven byshared antigens are present in the gut and liver of PSC-IBD patients. Ourfindings support efforts to therapeutically target memory T-cell recruitment inPSC-IBD.
KW - high-throughput sequencing
KW - human gut
KW - human liver
KW - IBD
KW - PSC
KW - T-cell receptor
KW - ulcerative colitis
U2 - 10.1016/j.jhep.2016.09.002
DO - 10.1016/j.jhep.2016.09.002
M3 - Article
SN - 0168-8278
JO - Journal of Hepatology
JF - Journal of Hepatology
ER -